Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cerebral Palsy × durvalumab × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 43 Triple Negative Breast Neoplasms 23 Ovarian Neoplasms 8 Melanoma 8 Neoplasm Metastasis 7 Prostatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 3 Carcinoma, Merkel Cell 3 Lung Neoplasms 2 Kidney Neoplasms 2 Hodgkin Disease 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma Of Esophagus 2 Uterine Neoplasms 1 Thyroid Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05215106 2024-07-08

POP-DURVA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Recruiting

Cerebral Palsy, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡